Company
Every investor coverage indicates participated in a round The Fertility Partners raised.
Companies The Fertility Partners acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming The Fertility Partners. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Growth investor HEAL Partners has reached a second close of about A$200 million for its health-and-education fund, with a mid-2025 final close targeted; its portfolio includes Removery and The Fertility Partners.
HEAL Partners led a US$10 million round in Crimson Education at a US$460 million valuation, with earlier backers topping up; the post also recalls Crimson's 2019 Series C and other companies HEAL has backed.